The SHELTER Trial of Transplanting Hepatitis C Virus–Infected Lungs Into Uninfected Recipients

The SHELTER Trial of Transplanting Hepatitis C Virus–Infected Lungs Into Uninfected Recipients

Background. SHELTER is a trial of transplanting lungs from deceased donors with hepatitis C virus (HCV) infection into HCV-negative candidates (sponsor: Merck; NCT03724149). Few trials have reported outcomes using thoracic organs from HCV-RNA+ donors and none have reported quality of life (QOL). Met...

Full description

Bibliographic Details
Main Authors: Peter P. Reese, MD, PhD, Joshua M. Diamond, MD, MSCE, David S. Goldberg, MD, MSCE, Vishnu Potluri, MD, MPH, Stacey Prenner, MD, Emily A. Blumberg, MD, Vivianna M. Van Deerlin, MD, PhD, K. Rajender Reddy, MD, Heather Mentch, MBE, Richard Hasz, MFS, CPTC, Ashley Woodards, MPH, Caren Gentile, MS, Jennifer Smith, BS, Christian Bermudez, MD, Maria M. Crespo, MD
Format: Article
Language:English
Published: Wolters Kluwer 2023-07-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001504

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001504

Similar Items